Anika Therapeutics (ANIK) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Anika Therapeutics (ANIK) over the last 16 years, with Q3 2025 value amounting to 0.77.
- Anika Therapeutics' Equity Ratio fell 29.78% to 0.77 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.77, marking a year-over-year decrease of 29.78%. This contributed to the annual value of 0.76 for FY2024, which is 316.08% down from last year.
- According to the latest figures from Q3 2025, Anika Therapeutics' Equity Ratio is 0.77, which was down 29.78% from 0.79 recorded in Q2 2025.
- In the past 5 years, Anika Therapeutics' Equity Ratio ranged from a high of 0.84 in Q1 2022 and a low of 0.76 during Q4 2024
- In the last 5 years, Anika Therapeutics' Equity Ratio had a median value of 0.8 in 2024 and averaged 0.8.
- In the last 5 years, Anika Therapeutics' Equity Ratio skyrocketed by 2062.32% in 2021 and then crashed by 570.04% in 2024.
- Anika Therapeutics' Equity Ratio (Quarter) stood at 0.83 in 2021, then fell by 0.98% to 0.82 in 2022, then fell by 4.11% to 0.78 in 2023, then fell by 3.16% to 0.76 in 2024, then grew by 2.03% to 0.77 in 2025.
- Its Equity Ratio was 0.77 in Q3 2025, compared to 0.79 in Q2 2025 and 0.78 in Q1 2025.